Boxer Capital’s Reata Pharmaceuticals RETA Stock Holding History
Bought
Maintained
Sold
Other funds holding RETA
Boxer Capital's RETA Position: Q3 2023 in Review
Boxer Capital sold out of Reata Pharmaceuticals (RETA) in Q3 2023, closing a stake of 1,430,004 shares — an estimated $146M sold.
Boxer Capital first reported a position in RETA in Q3 2017 and held it in 11 quarters. The position peaked at $146M in Q2 2023. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.
- Boxer Capital reported no remaining Reata Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
- Boxer Capital sold 1,430,004 Reata Pharmaceuticals shares in Q3 2023, an estimated $146M.
- Boxer Capital first reported a position in Reata Pharmaceuticals in Q3 2017 and held it in 11 quarters.
- Boxer Capital's Reata Pharmaceuticals position peaked at $146M in Q2 2023.
- 2 funds tracked by Wall St. Rank held Reata Pharmaceuticals as of Q3 2023.
Based on Boxer Capital's 13F filing for Q3 2023, filed 14 Nov 2023.